Ju-Won Roh Selected Research

Ju-Won Roh Research Topics

Disease

12	Neoplasms (Cancer) 05/2020 - 05/2006
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 05/2005
4	Neoplasm Metastasis (Metastasis) 05/2011 - 05/2006
3	Uterine Neoplasms (Uterine Cancer) 01/2021 - 04/2014
3	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 05/2010
3	Carcinoma (Carcinomatosis) 04/2014 - 05/2013
2	Ovarian Neoplasms (Ovarian Cancer) 09/2011 - 04/2011
1	Uterine Cervical Dysplasia 11/2023
1	Margins of Excision 11/2023
1	Squamous Intraepithelial Lesions 04/2020
1	Hemorrhage 01/2020
1	Endometriosis 01/2020
1	Pain (Aches) 01/2018
1	Pancreatitis 09/2017
1	Abdominal Pain (Pain, Abdominal) 09/2017
1	Disease Progression 09/2017
1	Dysmenorrhea (Menstrual Pain) 08/2011
1	Sarcoma (Soft Tissue Sarcoma) 05/2011
1	Endometrial Stromal Sarcoma 05/2011
1	Carcinosarcoma 05/2011
1	Leiomyosarcoma 05/2011
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Adenocarcinoma 01/2010
1	Papilloma (Papillomatosis) 10/2009
1	Lymphatic Metastasis 03/2007
1	Hypoxia (Hypoxemia) 05/2006

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 01/2020 - 04/2011
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 04/2020 - 05/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2013
2	Taxoids (Taxanes)IBA 01/2020 - 01/2014
2	Docetaxel (Taxotere)FDA Link 01/2014 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 04/2011
2	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2013 - 04/2011
2	Carbonic Anhydrase IXIBA 03/2007 - 05/2006
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2007 - 05/2006
1	Therapeutic UsesIBA 01/2024
1	Lugol's solution (Lugol's iodine)IBA 11/2023
1	Progestins (Progestagens)IBA 01/2020
1	dienogest FDA Link 01/2020
1	Progesterone FDA LinkGeneric 01/2020
1	ChitosanIBA 01/2020
1	Estrogens (Estrogen)FDA Link 09/2017
1	Monoclonal AntibodiesIBA 05/2014
1	Dasatinib (BMS 354825)FDA Link 04/2014
1	olaratumabIBA 01/2014
1	PlatinumIBA 05/2013
1	SK&F 82958 (SKF 82958)IBA 05/2013
1	CatecholaminesIBA 05/2013
1	Dopamine (Intropin)FDA LinkGeneric 05/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 05/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2013
1	Enhancer of Zeste Homolog 2 ProteinIBA 02/2013
1	Bevacizumab (Avastin)FDA Link 09/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011
1	LigandsIBA 09/2011
1	sericiteIBA 08/2011
1	Analgesics (Analgesic Drugs)IBA 08/2011
1	ParaffinIBA 05/2011
1	EnzymesIBA 05/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2011
1	HDL LipoproteinsIBA 04/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 04/2011
1	MEDI-547IBA 05/2010
1	Immunoconjugates (Immunoconjugate)IBA 05/2010
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	Codon (Codons)IBA 01/2010
1	Oxygen (Dioxygen)IBA 03/2007
1	Messenger RNA (mRNA)IBA 05/2006
1	Indicators and Reagents (Reagents)IBA 05/2006

Therapy/Procedure

5	Therapeutics 01/2024 - 05/2006
3	Radiotherapy 10/2009 - 05/2006
1	Adjuvant Chemotherapy 05/2020
1	Neoadjuvant Therapy 05/2020
1	Duration of Therapy 01/2020
1	Length of Stay 01/2018
1	Aftercare (After-Treatment) 08/2011
1	Drug Therapy (Chemotherapy) 05/2010
1	Trachelectomy 09/2007
1	Hysterectomy 09/2007
1	Lymph Node Excision (Lymph Node Dissection) 09/2005
1	Chemoradiotherapy 05/2005